Merck & Co. kept Neutral rating but price target raise to $93 from $89 at BofA Securities
Merck & Co. Inc. (NYSE: MRK): BofA Securities kept a Neutral rating on the pharmaceutical heavyweight while raising the $89 price target to $93. The consensus target is $97.61. The stock closed higher on Wednesday at $92.51.
Market Recomendation
Fundamental News - S&P500
21 Apr 2022US stock futures rose on Thursday after a mixed session on Wall Street as investors digested more quarterly reports against a backdrop of elevated inflation and further monetary tightening. Dow...
Fundamental News - DJI5R
21 Apr 2022US stock futures rose on Thursday after a mixed session on Wall Street as investors digested more quarterly reports against a backdrop of elevated inflation and further monetary tightening. Dow...
Fundamental News - XAUUSD
21 Apr 2022Gold Price is in a narrow consolidative range so far this Thursday having stalled its rebound just shy of the key $1960 level.Gold Price could see further downside risks in...